Immunosuppressants exert their activity by binding to immunophilins, an evolutionary conserved, but structurally heterogeneous family of proteins that shares a common enzymatic activity and pharmacological profile (1-3). All immunophilins described to date possess cis-trans-peptidylprolyl isomerase or rotamase activity, which has been implicated in the folding, assembly, and trafficking of target proteins in vivo (1, 2). The cis-trans-peptidylprolyl isomerase activity is inhibited by low concentrations of immunosuppressants. Based upon binding criteria, immunophilins are divided into two classes: (a) the cyclophilin family that selectively binds cyclosporin A (CSA) 1 and (b) the FK-506 binding proteins (FKBP), which bind to FK-506, its analogues, and rapamycin. Although the precise functions of immunophilins and their downstream targets remain to be determined, they have frequently been implicated in regulating a variety of Ca 2ϩ -dependent pathways. The best characterized therapeutic action of CSA or FK-506 is the suppression of interleukin-2 gene transcription during antigeninduced T-lymphocyte activation. Specifically, CSA⅐cyclophilin or FK-506⅐FKBP complexes are targeted to and inhibit the catalytic activity of the Ca 2ϩ /calmodulin-dependent protein phosphatase, calcineurin (4), thereby blocking the translocation of nuclear factor of activated T cells (3, 5).
Immunosuppressants exert their activity by binding to immunophilins, an evolutionary conserved, but structurally heterogeneous family of proteins that shares a common enzymatic activity and pharmacological profile (1-3). All immunophilins described to date possess cis-trans-peptidylprolyl isomerase or rotamase activity, which has been implicated in the folding, assembly, and trafficking of target proteins in vivo (1, 2) . The cis-trans-peptidylprolyl isomerase activity is inhibited by low concentrations of immunosuppressants. Based upon binding criteria, immunophilins are divided into two classes: (a) the cyclophilin family that selectively binds cyclosporin A (CSA) 1 and (b) the FK-506 binding proteins (FKBP), which bind to FK-506, its analogues, and rapamycin. Although the precise functions of immunophilins and their downstream targets remain to be determined, they have frequently been implicated in regulating a variety of Ca 2ϩ -dependent pathways. The best characterized therapeutic action of CSA or FK-506 is the suppression of interleukin-2 gene transcription during antigeninduced T-lymphocyte activation. Specifically, CSA⅐cyclophilin or FK-506⅐FKBP complexes are targeted to and inhibit the catalytic activity of the Ca 2ϩ /calmodulin-dependent protein phosphatase, calcineurin (4) , thereby blocking the translocation of nuclear factor of activated T cells (3, 5) .
In isolated mitochondria, CSA binds to cyclophilin D (CyP-D), which is believed to be a component of the mitochondrial permeability transition pore (PTP). Displacing CyP-D from its binding site favors the closed state of the pore (6 -8) . Recent evidence suggests that the PTP may be involved in Ca 2ϩ signaling (9, 10) , as well as necrotic and apoptotic cell death (11) (12) (13) (14) (15) . Operating in a low conductance mode, the PTP is also proposed to furnish mitochondria with a fast Ca 2ϩ -efflux mechanism (i.e. mitochondrial calcium-induced calcium-release) that, in turn, amplifies inositol 1,4,5-trisphosphate (IP 3 )-dependent cytosolic calcium ([Ca 2ϩ ] i ) signals (9, 10) . Immunophilins may also modulate the Ca 2ϩ release channels of the internal stores directly. FKBP12 forms tight complexes with both ryanodine receptors (RyRs) and IP 3 receptors (IP 3 Rs) that are perturbed by FK-506 or rapamycin (16 -19) . Dissociation of the FKBP from the channels results in increased Ca 2ϩ fluxes in response to caffeine or IP 3 (16, 18) . This enhanced Ca 2ϩ release can either be explained by destabiliza- 1 The abbreviations used are: CSA, cyclosporin A; IP 3 , inositol 1,4,5-trisphosphate; IP 3 R, inositol 1,4,5-trisphosphate receptor; RyRs, ryanodine receptors; ER, endoplasmic reticulum; PE, phenylephrine; VP, vasopressin; MeVal-CS, N-methylvaline-cyclosporin; CyP-D, cyclophilin D; [Ca 2ϩ ] m , mitochondrial matrix-free Ca 2ϩ concentration; [Ca 2ϩ ] i , cytosolic-free Ca 2ϩ concentration; [Ca 2ϩ ] ex , medium-free Ca 2ϩ concentration; PMF, proton motive force; ⌬⌿ m , mitochondrial membrane potential; FKBP, FK-506 binding protein; PTP, permeability transition pore; MES, 4-morpholineethanesulfonic acid; ICM, intracellular-like media; TMREE, tetramethylrhodamine ethyl ester; PKC, protein kinase C; Tg, thapsigargin; SERCA, sarco-endoplasmic reticulum Ca 2ϩ -ATPase; BAPTA, 1,2-bis(2-aminophenoxy)ethane-N,N,NЈ,NЈ-tetraacetic acid; FK-506, tacrolimus; FCCP, carbonyl cyanide p-(tri-fluoromethoxy)phenyl-hydrazone; BTC, glycine, N- [3-(2- tion of the channel following FKBP12 dissociation (3, 16) or a change in the phosphorylation state, because FKBP12 also anchors calcineurin to the channel (17) . Moreover, two ubiquitously expressed members of the cyclophilin family, s-cyclophilin and cyclophilin A, colocalize with or bind to the Ca 2ϩ storage protein of the ER, calreticulin (20, 21) . Therefore, this raises the possibility that cyclophilins may modulate Ca 2ϩ storage properties of the ER and, indirectly, Ca 2ϩ flux through the RyR and/or IP 3 R. Taken together, there is a wealth of evidence that immunophilins can potentially activate or inhibit Ca 2ϩ -dependent signal transduction by modifying the activity of diverse cellular targets.
Periodic oscillations or spikes in [Ca 2ϩ ] i are utilized by a wide range of extracellular stimuli (22) (23) (24) and are decoded by a host of downstream sensors (25) (26) (27) (28) . In non-excitable tissues, extracellular agonists mediate increases in [Ca 2ϩ ] i through the formation of the second messenger IP 3 and activation of intracellular Ca 2ϩ -release channels (22) (23) (24) 29) , which may in turn stimulate the influx of external Ca 2ϩ to sustain the agonist signal and refill the internal stores (30 
EXPERIMENTAL PROCEDURES
Materials-Cyclosporin A and MeVal-CS were generous gifts from Novartis (Basil, Switzerland) and FK-506 from Fujisawa, Inc. Stock solutions were prepared in Me 2 SO and diluted at least a 1000-fold in all experiments.
Cell Isolation and Culture-Hepatocytes were isolated by a two-step collagenase perfusion of livers from male Sprague-Dawley rats fed ad libitum as described previously (33) . Isolated hepatocytes were stored on ice until assayed or maintained in primary culture for 1.5-3 h in Williams' E medium supplemented with 10% (v/v) fetal calf serum (complete WEM) as described previously (28) . Hepatocytes used in confocal imaging experiments were cultured overnight in complete WEM containing insulin (14 nM). Prior to use, cells were incubated 30 -40 min in a KR-HEPES buffer composed of (in millimolar): 121 NaCl, 25 Na-HEPES, 5 NaHCO 3 , 4.7 KCl, 1.2 KH 2 PO 4 , 1.2 MgSO 4 , 2 CaCl 2 , 10 glucose, 0.1 sulfobromophthalein, and 0.25% (w/v) essentially fatty acid-free bovine serum albumin (fraction V, Sigma Chemical Co.), pH 7.4, at 37°C. Where indicated in the figure legends, L-glutamate (5 mM) and pyruvate (1 mM) were also present during the incubation period.
Single Cell [Ca 2ϩ ] i Measurements-Ca 2ϩ imaging experiments were preformed essentially as described previously (33, 34) . Briefly, hepatocytes attached to collagen (5 g/cm 3 )-coated glass coverslips were loaded with fura-2 by incubation with 5 M fura-2/AM for 15-30 min in a KR-HEPES buffer supplemented with 0.2% (w/v) Pluronic acid F-127. Fura-2-loaded hepatocytes were washed twice with KR-HEPES without dye or Pluronic acid and then transferred to a thermostatically regulated microscope chamber (37°C). Fura-2 fluorescence images (excitation 340 and 380 nm, emission 420 -600 nm) were acquired at 1-to 3-s intervals with a cooled charged-coupled device camera under computer control (33, 34) . Calibration of fura-2 in terms of [Ca 2ϩ ] i was calculated from the 340/380 nm ratio after correcting for autofluorescence (35) . Autofluorescence values were obtained at the end of each experiment by permeabilizing the cells with digitonin in an intracellular-like media containing a Ca 2ϩ /EGTA buffer and Mg⅐ATP (35) . The fura-2 calibration parameters were determined in vitro using a K d value of 224 nM.
Single Cell Measurements of ⌬⌿-Primary cultured hepatocytes were incubated with tetramethylrhodamine ethyl ester (TMREE, 5 nM) for 1-2 h in complete WEM then washed into a KR-HEPES buffer containing 5 nM TMREE. TMREE fluorescence images were collected using 548-nm excitation and 600-nm-long bandpass emission filter. The logarithm of TMREE fluorescence changes was normalized to the fluorescence intensity values obtained after collapsing the mitochondrial electrochemical gradient with 5 M FCCP plus 5 g/ml oligomycin.
Laser Scanning Confocal Microscopy-Simultaneous measurement of Mito Tracker Green and rhod-2 fluorescence were performed as described previously (33, 36) . Briefly, overnight-cultured hepatocytes were incubated with 100 nM Mito Tracker Green for 1-2 h in complete WEM supplemented with 0.05% (w/v) Pluronic acid F-127. Cells were washed extensively and then loaded with rhod-2/AM (10 M) in KR-HEPES buffer containing Pluronic acid F-127 (0.1% w/v) for 10 min at room temperature. Confocal images were acquired using a Bio-Rad MRC 600 laser scanning confocal microscope.
Mitochondrial Ca 2ϩ Uptake in Permeabilized Hepatocyte-Hepatocytes (5 mg/ml cell protein) were washed once in a Ca 2ϩ -free intracellular-like buffer (IB) composed of (in millimolar): 135 KCl, 15 NaCl, 1.2 MgSO 4 , 1.2 KH 2 PO 4 , 10 HEPES, 10 MES, 5 glutamate, 1 pyruvate, 10 units/ml aprotinin, and 1 g/ml each of leupeptin, antipain, and pepstatin A (pH 7.2 at 37°C), and then stored on ice. Prior to use, cells were briefly centrifuged, suspended in prewarmed IB, and then incubated for 5 min in the presence of indicated drugs or vehicle. Incubations were carried out in a thermostatically regulated cuvette (37°C) with continuous stirring. The cells were permeabilized with digitonin (25 g/ml), and the medium was further supplemented with 5 mM phosphocreatine, 5 units/ml creatine phosphokinase, 2 mM ATP⅐K, 2 M thapsigargin, and 10 M BTC-free acid (Molecular Probes). BTC fluorescence (excitation 405 and 470 nm, emission 540) was monitored using a dualwavelength excitation spectrofluorimeter. Calibration of BTC fluorescence ratio values was achieved by determining the minimum and maximum 405/470 ratios with EGTA/Tris and excess CaCl 2 , respectively, at the end of each run (35 3 -induced Ca 2ϩ release in permeabilized hepatocyte suspensions was performed essentially as described previously (38) . Hepatocytes (5 mg/ml cell protein) were washed extensively in a Ca 2ϩ -free Chelex-treated intracellular-like media (ICM) composed of (in millimo-lar): 130 KCl, 10 NaCl, 1.0 KH 2 PO 4 , 20 HEPES, 20 Tris, 5 glutamate, 1 pyruvate, 10 units/ml aprotinin, and 1 g/ml each of leupeptin, antipain, and pepstatin A (pH 7.2 at 37°C), then stored on ice. Prior to the experiment, cells were washed into prewarmed ICM supplemented with phosphocreatine (5 mM) and fura-2-free acid (5 M) then incubated for 5 min in a stirred thermostatted cuvette. When indicated in the figure legends, CSA (5 M) or Me 2 SO vehicle (0.1%, v/v) was included during the preincubation period. Cells were permeabilized with digitonin (40 g/ml) in the presence of 5 units/ml creatine phosphokinase for 2 min followed by addition of 2 mM Mg⅐ATP to initiate Ca 2ϩ uptake. In some experiments, mitochondrial Ca 2ϩ uptake was inhibited by adding rotenone (5 M) plus oligomycin (5 g/ml) prior to permeabilization. fura-2 fluorescence changes were monitored as described in the previous section. IP 3 -induced Ca 2ϩ release was normalized to the size of the ionomycin-releasable Ca 2ϩ pool. In parallel experiments, the Ca 2ϩ content of the ionomycin-sensitive Ca 2ϩ store was determined. After cell permeabilization, rotenone, oligomycin, FCCP (0.5 M), and Mg⅐ATP were added and the cell suspension incubated for 15 min. FCCP was included to help facilitate the release of stored mitochondrial matrix Ca 2ϩ . The size of the ionomycin-releasable Ca 2ϩ store was calibrated by small additions of standardized CaCl 2 to the cuvette. Under these conditions, the size of the thapsigargin-sensitive Ca 2ϩ pool was 90 -95% of the ionomycin-sensitive Ca 2ϩ pool. Protein Determination-Protein content was determined by alkaline biuret assay using the methods described by the manufacture (Sigma).
Statistical Analysis-Unless otherwise stated in the text, all experiments were repeated with at least three separate hepatocyte preparations. Data are presented as means Ϯ S.E. for the number of separate hepatocyte preparations shown in parentheses. Significance of differences from the relevant controls was calculated by Student's t test. Another possible mechanism of action for the CSA⅐cyclophilin complex is the inhibition of calcineurin (3, 5) , which is known to increase PKC-dependent phosphorylation of IP 3 Rs in isolated cerebellar microsomes (17) . The CSA derivative, MeVal-CS, binds cyclophilins with a similar efficacy to CSA (39) , but the complex cannot inhibit calcineurin activity (40 -42) . The addition of MeVal-CS (5 M) also inhibited the frequency of PEinduced [Ca 2ϩ ] i oscillations ( Fig. 1C ) in a concentration-dependent manner (data not shown) with a potency similar to CSA. Furthermore, a 10-to 15-min preincubation with a PKC inhibitor, bisindolylmaleimide-1 (0.1-1.0 M), did not block the inhibitory effects of CSA on PE-induced [Ca 2ϩ ] i responses (data not shown). Taken together, these data suggest that CSAinduced inhibition of IP 3 -dependent Ca 2ϩ signals is not mediated by either PKC or calcineurin.
RESULTS

CSA Inhibits [Ca
In some cell types, IP 3 -induced Ca 2ϩ release has been proposed to trigger calcium-induced calcium-release via RyRs. ] i , peak amplitude and time to peak were the same before and after CSA addition (Fig. 2 , A and C), although there was a small, but significant, increase in the rate of Ca 2ϩ rise (p Ͻ 0.001; Fig. 2D ). The most obvious effect of CSA on the kinetics of the individual [Ca 2ϩ ] i spikes was to slow the rate of decline (p Ͻ 0.001), resulting in a prolongation of the Ca 2ϩ transient (Fig. 2, B (Fig. 3A) . This sustained phase of [Ca 2ϩ ] i increase is dependent upon Ca 2ϩ influx and is set by the balance between Ca 2ϩ influx and efflux across the plasma membrane (cf. Fig. 3D ). In Fig. 3A , BAPTA was added during the sustained rise in [Ca 2ϩ ] i to abruptly inhibit Ca 2ϩ influx. The initial rate of Ca 2ϩ clearance from the cytosol, which mostly reflects Ca 2ϩ efflux mechanisms, was unaltered by CSA pretreatment (Fig. 3A, gray trace ). An alternative method to assess efflux rates is to measure the appearance of Ca 2ϩ in the external buffer after mobilizing internal stores. In cell suspension experiments, CSA pretreatment did not effect the rate of Ca 2ϩ efflux elicited by the addition of maximal concentrations of either VP or thapsigargin (Tg) (not shown).
In Fig. 3B , hepatocytes were stimulated with maximal VP for ] i spike were measured as described previously (34) .
CSA Inhibits IP 3 -dependent Ca 2ϩ Responses
(PMF), thus inhibiting mitochondrial Ca 2ϩ uptake. Oligomycin (Oligo) was included in these experiments to limit FCCP-stimulated ATP hydrolysis (33 (Fig. 4D) . Furthermore, when MeVal-CS was substituted for CSA, qualitatively similar results were obtained for each experimental protocol shown in Fig. 4 , indicating that these effects were independent of calcineurin (not shown). These data suggest that the decrease in basal [Ca 2ϩ ] i is mediated by Ca 2ϩ uptake into internal stores via SERCA. Permeabilized hepatocytes suspensions were used to further investigate the effects of CSA on Ca 2ϩ uptake into internal stores in the presence of inhibitors to block mitochondrial Ca 2ϩ transport. Fig. 5A uptake (mean Ϯ S.E.; n ϭ 3). Once steady-state Ca 2ϩ uptake reached completion, ionomycin was used to check the final store size. Despite enhancing the rate of Ca 2ϩ uptake, the ionomycin-sensitive Ca 2ϩ pool was not significantly increased in the presence of CSA. The final steady-state Ca 2ϩ pool was 2.75 Ϯ 0.1 and 2.88 Ϯ 0.1 nmol/mg of protein in the absence and presence of CSA, respectively (p Ͼ 0.1; n ϭ 3).
In parallel experiments, Tg was added to assess the passive Ca 2ϩ leak rate from internal stores (Fig. 5B) fluxes were still smaller in CSA-treated cells, indicating that the shift in receptor sensitivity is not mediated by the different baseline [Ca 2ϩ ] ex levels (not shown). Moreover, including ryanodine (100 -200 M) in the permeabilization buffer did not change the effects of CSA on IP 3 R sensitivity, suggesting that RyRs are not involved in the action of CSA (not shown).
The most striking effect of CSA treatment is the decrease in the size of the IP 3 -sensitive Ca 2ϩ pool. The blunted Ca 2ϩ fluxes cannot be explained by differences in pool size, because the ionomycin-releasable Ca 2ϩ pool is not significantly increased in CSA-treated cells (see text). Moreover, CSA did not modify the initial rate of Ca 2ϩ release at maximal IP 3 concentrations, the fura-2 ratio increased 0.94 Ϯ 0.05 unit/s in Me 2 SO-treated cells verses 0.89 Ϯ 0.05 unit/s in CSA-treated cells (p Ͼ 0.2; n ϭ 3). The lack of effect on initial rates of IP 3 -induced Ca 2ϩ release, coupled with the increased rate of [Ca 2ϩ ] i rise in the intact cells (Fig. 2D) , suggest that CSA did not directly inhibit Ca 2ϩ flux through the IP 3 R.
CSA has been reported to increase the size of the mitochondrial Ca 2ϩ pool in intact cells (47, 48 ). An enhanced rate of mitochondrial Ca 2ϩ uptake could buffer IP 3 -induced [Ca 2ϩ ] ex responses. To test this possibility, hepatocyte suspensions were treated with mitochondrial inhibitors prior to digitonin permeabilization. Blocking mitochondrial Ca 2ϩ uptake resulted in a less pronounced rightward shift in the IP 3 concentration response curve but did not eliminate the effects of CSA on the IP 3 -sensitive Ca 2ϩ store size (Fig. 6B) . The EC 50 values were 128 and 148 nM in the absence and presence of CSA, respectively. These data suggest that the mitochondria are not in- (33, 36) , VP stimulation rapidly increased rhod-2 fluorescence in individual mitochondria (Fig. 7A) . Analysis of rhod-2 fluorescence changes (500 -1000 mitochondria per cell) revealed that CSA pretreatment increased the rate of rise in [Ca 2ϩ ] m after VP stimulation from 8.3 Ϯ 2.5%/s to 21.7 Ϯ 5.8%/s (p Ͻ 0.05; n ϭ 2-4 cells). It is worth re-emphasizing that CSA did not alter the rate nor the magnitude of VP-induced [Ca 2ϩ ] i responses (Fig. 3A) , indicating that rhod-2 is reporting a differential effect on mitochondrial Ca 2ϩ uptake in situ. No significant differences in the magnitude of [Ca 2ϩ ] m responses could be detected with rhod-2; fluorescence intensities increased 210 Ϯ 34% and 240 Ϯ 7% above basal values in the absence and present of CSA, respectively (p Ͼ 0.5). However, this may reflect saturation of rhod-2.
The total accumulation of mitochondrial matrix Ca 2ϩ during a rise in [Ca 2ϩ ] i was measured in intact hepatocyte suspensions (49) pretreated with maximal VP (Fig. 7B) or VP plus Tg (Fig. 7C ). Cells were quickly washed into a BAPTA-containing medium plus fura-2-free acid, and the compartmentalized Ca 2ϩ was released by ionomycin (Iono). CSA significantly increased the amount of Ca 2ϩ accumulated by the mitochondria during VP stimulation (Fig. 7B ). Under these conditions, the ionomycin-releasable Ca 2ϩ pool predominately originated from the mitochondria, because the same effect was also observed in cells treated with VP plus Tg (Fig. 7C) . Moreover, greater than 90% of the ionomycin-releasable Ca 2ϩ pool was blocked by including mitochondrial inhibitors during the preincubation period (Fig. 7C, FCCP) . In the presence of VP alone, CSA increased mitochondrial Ca 2ϩ content from 3.9 Ϯ 0.7 to 12.6 Ϯ 1.9 nmol/mg of mitochondrial protein (p Ͻ 0.05; mean Ϯ S.E., n ϭ 3). In VP-plus Tg-treated hepatocytes, matrix Ca 2ϩ content was 13.6 Ϯ 0.8 and 21.2 Ϯ 1.3 nmol/mg of mitochondrial protein in the absence and presence of CSA, respectively (p Ͻ 0.05; mean Ϯ S.E., n ϭ 3).
CSA is known to decrease the open probability of the mitochondrial PTP (6) , which in some cell types leads to an increase in mitochondrial membrane potential (⌬⌿ m ) (50, 51) . Because the initial rate of mitochondrial Ca 2ϩ uptake is proportional to the magnitude of ⌬⌿ m (52), we explored the possibility that CSA mediates its effect through changes in ⌬⌿ m . We have shown previously that real-time measurement of ⌬⌿ m can be achieved in intact cells using the fluorescent indicator, tetramethylrhodamine ethyl ester (TMREE) (33, 36) . Addition of CSA to naive cells caused a stable increase in the mean TM-REE fluorescence, indicating a rise in ⌬⌿ m corresponding to a 1-2% increase in the logarithm of the fluorescence ratio (Fig.  7D ). This observation is consistent with a constitutively active mitochondrial PTP or megachannel operating in a low conductance mode (i.e. flickering). For comparison, hepatocytes were subsequently treated with K ϩ /H ϩ ionophore, nigericin (Nig, Fig. 7D ), that slowly abolishes the mitochondrial proton gradient converting the free energy into ⌬⌿ m (36) and, thus, hyperpolarizes the mitochondrial inner membrane.
To further investigate the effects of CSA on mitochondrial Ca 2ϩ transport without the interference of plasma membrane Ca 2ϩ transporters, we returned to the permeabilized hepatocyte preparation. In these experiments, Tg was added to preclude any CSA-dependent effects on the SERCA pumps and a low affinity Ca 2ϩ indicator dye (BTC; K d ϭ 7 M) was employed to measure [Ca 2ϩ ] ex . A CaCl 2 pulse (30 nmol/mg of cell protein) to pre-energized mitochondria initiated Ca 2ϩ uptake (Fig. 8A 
digitonin permeabilization significantly enhanced the initial rate of mitochondrial Ca 2ϩ uptake (Fig. 8, A and B ; p Ͻ 0.05), consistent with the rhod-2 measurements in intact hepatocytes (Fig. 7A) . Ruthenium red (1 M) was added after Ca 2ϩ uptake to block the mitochondrial uniporter, thus permitting the measurement of Ca 2ϩ efflux rates (Fig. 8C) . Addition of ruthe- 
nium red prior to the Ca 2ϩ pulse completely blocked all Ca 2ϩ uptake (not shown). CSA dramatically suppressed the rate of Ca 2ϩ egress (p Ͻ 0.05; Fig. 8, C and D) , which could account for the large increase in mitochondrial Ca 2ϩ content measured in the intact hepatocytes (Fig. 7, B and C) . As expected, FK-506 did not affect mitochondrial Ca 2ϩ fluxes (Fig. 8) , consistent with intact cell data and the absence of FKBP immunophilins in the mitochondrial matrix (2) . Taken together, these results suggest that the higher ⌬⌿ m in the presence of CSA can increase the driving force for mitochondrial Ca 2ϩ uptake. ] i peak height was 466 Ϯ 43 nM and 497 Ϯ 26 nM in the absence and presence of mitochondrial toxins, respectively (mean Ϯ S.E.; n ϭ 100 -125 cells, nine cell preparations). In the presence of mitochondrial inhibitors, the inhibitory effects of CSA on PE-induced [Ca 2ϩ ] i responses was significantly reduced (Fig. 9B, ϩCSA) . CSA inhibited the frequency of PE-induced [Ca 2ϩ ] i oscillations by 62 Ϯ 2% under physiological conditions, but by only 38 Ϯ 2% after blocking mitochondrial Ca 2ϩ uptake (p Ͻ 0.001). Thus, blocking mitochondrial Ca 2ϩ uptake reduced the effects of CSA on both IP 3 -dependent [Ca 2ϩ ] i oscillations in intact cells (Fig. 9B) and IP 3 -induced Ca 2ϩ release in permeabilized hepatocytes (Fig.  6B) , indicating that mitochondria contribute to the decrease in IP 3 R sensitivity.
The rates of rise and fall of individual [Ca 2ϩ ] i spikes were significantly increased in the presence of mitochondrial inhibitors (p Ͻ 0.001; compare Fig. 2, D-E, with Fig. 9, D-E) . However, CSA did not significantly affect the kinetics of the [Ca 2ϩ ] i spikes under these conditions (Fig. 9, C-E) . Thus, the disruption of mitochondrial Ca 2ϩ transport eliminated the effects of CSA on the shape of the [Ca 2ϩ ] i spike. Half-peak width was 10.6 Ϯ 0.4 and 11.7 Ϯ 0.5 s before and after CSA, respectively (p Ͼ 0.05). These data suggest that the CSA-mediated decrease in the declining phase of the [Ca 2ϩ ] i spike, observed in the absence of mitochondrial inhibitors (Fig. 2E) , could be explained by an increase in total mitochondrial Ca 2ϩ content (Fig.  7B ) coupled with slower mitochondrial Ca 2ϩ egress (Fig. 8D ).
DISCUSSION
Regulation of Ca 2ϩ
Transport Mechanisms-The ubiquitous tissue expression, broad subcellular distribution, and multiple protein targets situate the cyclophilin family at a critical juncture to regulate a diverse array of cellular activities (1-3, 5) . Our study has identified two distinct effects of CSA on Ca 2ϩ transport pathways in hepatocytes: Tg-sensitive Ca 2ϩ pumps and mitochondrial Ca 2ϩ uptake and retention. MeVal-CS has similar effects on Ca 2ϩ transport mechanisms, indicating that calcineurin is probably not involved. Thus, it would appear that specific cyclophilin isozymes directly regulate these cellular Ca 2ϩ transport mechanisms. In intact hepatocytes, CSA or MeVal-CS stimulated a Tgsensitive decrease in baseline [Ca 2ϩ ] i under resting conditions or during agonist stimulation (Figs. 1-4) . This effect on free Ca 2ϩ levels could be fully reconstituted in a permeabilized cell system, pointing to an ER-associated cyclophilin as a possible mediator. Several mechanisms could contribute to lower [Ca 2ϩ ] ex in permeabilized hepatocytes: (a) decreased Ca 2ϩ leak from internal stores (b) increased luminal Ca 2ϩ -buffering capacity and/or (c) a change in the kinetics properties of the Ca 2ϩ pumps. Because CSA does not affect the size of the ionomycinsensitive Ca 2ϩ pool (see text) nor the passive Ca 2ϩ leak rate from internal stores (Fig. 5B) , the first two options do not appear to be major contributors. However, we cannot rule out the loss of cytosolic factors or partial disruption of ER integrity during permeabilization affecting our results. Nevertheless, the simplest explanation is a change in the kinetic properties of the Ca 2ϩ pump; an enhanced rate of Ca 2ϩ uptake and lower final set point for [Ca 2ϩ ] ex suggest an increased affinity for Ca 2ϩ . Previous studies have identified members of the cyclophilin family as calreticulin binding proteins (21) . In addition to its role as a Ca 2ϩ storage protein, calreticulin is also a lectin-like molecular chaperone and participates in the correct folding of newly synthesized glycoproteins (53) . Recently, it has been proposed that the chaperon domain of calreticulin might also specifically interact with the mature form of SERCA 2b to modulate IP 3 -mediated Ca 2ϩ release in Xenopus oocytes (54, 55) . SERCA 2b is the only isoform expressed in hepatocytes (56) and differs from other SERCA sub-types, containing an additional transmembrane domain that localizes a putative N-glycosylation site in the C-terminal to the ER lumen (53) . In oocytes, overexpression of calreticulin inhibits the repetitive [Ca 2ϩ ] i spikes induced by IP 3 microinjection, apparently by modulating the functional conformation and, thus, Ca 2ϩ transport activity of SERCA 2b (54, 55) . In this model, dissociation of calreticulin from SERCA 2b restores full enzymatic activity, whereas calreticulin binding reduces Ca 2ϩ transport. It is an intriguing possibility that the CSA⅐cyclophilin complex may directly inhibit calreticulin binding to the Ca 2ϩ pump. Alternatively, calreticulin and cyclophilin may form a complex with SERCA 2b, which is disrupted by CSA, a mechanism similar to displacing CyP-D from the mitochondrial PTP (6 -8) .
CSA is known to inhibit the PTP in isolated mitochondria and suppresses necrotic cell death associated with mitochondrial Ca 2ϩ overload in a variety of cells types (6, 12, 13) . The CSA-sensitive mitochondrial target is presumably CyP-D; CSA binding disassociates CyP-D from the PTP complex (7, 8) decreasing the open probability of the channel. Classic mitochondrial studies have put forward the concept that PTP opening has irreversible deleterious effects on mitochondrial function. This includes mitochondrial depolarization, release of matrix ions, and the loss mitochondrial metabolites into the cytosol (6) . However, more recent evidence suggests that the PTP operates in two distinct conducting states, high conductance involved in the irreversible opening of the pore, and a low conductance mode, more selective to protons and Ca 2ϩ (9, 10) . In hepatocytes, CSA promoted a stable increase in ⌬⌿ m (Fig. 7D ) consistent with the presence of a constitutively active but low conducting state of the PTP that partially dissipates the mitochondrial electrochemical gradient. CSA has also been shown to increase basal ⌬⌿ m in several other cell types using similar fluorescence imaging techniques (50, 51) . Moreover, a spontaneous and transient CSA-sensitive increase in membrane permeability has been reported in single isolated cardiac mitochondria and mitochondria in intact hepatocytes (57, 58) . Taken together, these data strongly suggest that CSA-sensitive "pores" or channels undergo cyclical opening and closing to contribute to the basal proton leak rate across the mitochondrial inner membrane.
CSA enhanced mitochondrial Ca 2ϩ uptake in both permeabilized and intact hepatocytes while inhibiting Ca 2ϩ egress (Figs.  7 and 8) . Ca 2ϩ transport across the mitochondrial inner membrane is regulated by components of the mitochondrial PMF. The large negative ⌬⌿ m drives mitochondrial Ca 2ϩ uptake through the Ca 2ϩ uniporter, whereas both ⌬⌿ m and the mitochondrial proton gradient can contribute to Ca 2ϩ efflux (59) . In isolated rat mitochondria, the initial rate of Ca 2ϩ uptake increases in proportion to the magnitude of ⌬⌿ m (52) . Thus, the CSA-induced rise in ⌬⌿ m is the most likely parameter mediating the enhanced rate of mitochondrial Ca 2ϩ uptake. In liver, mitochondrial Ca 2ϩ efflux is predominately mediated by a Na ϩ -independent mechanism, presumably H ϩ /Ca 2ϩ exchange, because the Na ϩ /Ca 2ϩ exchanger is suppressed by physiological concentrations of Mg 2ϩ in this tissue (59) . Both mitochondrial Ca 2ϩ efflux mechanisms have been proposed to be electrogenic (60, 61) and thus, Ca 2ϩ egress should be stimulated by a rise in ⌬⌿ m and not suppressed as we observed in this investigation (Fig. 8) . Thus, our data suggests two possible alternatives: (a) the low conducting mitochondrial PTP is the major Ca 2ϩ efflux pathway in hepatocytes or (b) the CSA⅐cyclophilin complex directly inhibits mitochondrial Ca 2ϩ efflux pathways.
Effect of CSA on IP 3 -dependent [Ca 2ϩ ] i Spikes-CSA and MeVal-CS both inhibited the frequency of PE-induced [Ca 2ϩ ] i oscillations in a concentration-dependent manner (Fig. 1) . In the case of CSA, we show a small, but reproducible, decrease in IP 3 sensitivity in permeabilized hepatocytes (Fig. 6) . The rightward shift in the IP 3 concentration response curve was sensitive to inhibitors that eliminated mitochondrial Ca 2ϩ uptake (Fig. 6B) . Moreover, the same inhibitor mixture decreased the effects of CSA on IP 3 -dependent Ca 2ϩ signals in intact hepatocytes (Fig. 9B) , indicating that Ca 2ϩ uptake by the mitochondria plays a role in shifting IP 3 R sensitivity both in vitro and in situ. We have previously reported that the close association between ER Ca 2ϩ release channels and mitochondrial Ca 2ϩ uptake sites allows the mitochondria to influence IP 3 R excitability by suppressing the local Ca 2ϩ gradients surrounding the mouth of the channel (32 (Fig. 9A) . Indeed, the decay rate of the [Ca 2ϩ ] i spike increased, not decreased as would be expected if ATP-dependent Ca 2ϩ transport was inhibited. Consequently, the effects of mitochondrial toxins on the kinetic properties of the [Ca 2ϩ ] i spike appear to be specific to blocking mitochondrial Ca 2ϩ transport and not due to a drop in cellular ATP levels.
Importantly, the effects of CSA on the kinetic properties of the [Ca 2ϩ ] i spike were eliminated in the presence of mitochondrial inhibitors (Fig. 9) (Fig. 2D ) is probably not due to its action on mitochondria, because inhibition of mitochondrial Ca 2ϩ uptake with uncoupler also enhanced the rate of [Ca 2ϩ ] i rise (Fig. 9D) (Fig. 7) , which is consistent with a lack of FKBPs in the mitochondrial matrix (2 (32) . In many cells, the ER envelops the mitochondria placing the mitochondrial Ca 2ϩ uptake sites in juxtaposition to the IP 3 Rs (68) or to the RyRs (69) . Thus, mitochondria have privileged access to the highly localized Ca 2ϩ gradients generated during ligand-induced ER Ca 2ϩ mobilization (28, 67, 70, 71) . This strategic location facilitates the activation of mitochondrial Ca 2ϩ uptake and, thus, Ca 2ϩ -dependent regulation of metabolic processes in the mitochondrial matrix (33, 36) . Moreover, in some cell types, these local Ca 2ϩ gradients may also serve as a trigging mechanism to open the mitochondrial PTP, resulting in mitochondrial calcium-induced calcium-release and amplification of IP 3 -dependent [Ca 2ϩ ] i spikes (9) . Our data are clearly consistent with the mitochondria playing an important role in setting the frequency and modulating the kinetic properties of IP 3 (Fig. 9 ) and modulate the propagation rate of intracellular Ca 2ϩ waves (32) . Finally, our data are not consistent with localized Ca 2ϩ gradients triggering the opening of the mitochondrial PTP. In hepatocytes, total mitochondrial PMF increases during IP 3 -dependent Ca 2ϩ mobilization (33, 36) inconsistent with the opening of a large pore in the inner mitochondrial membrane. Perhaps, the sluggish rate of mitochondrial Ca 2ϩ uptake, time-to-peak ϳ14 s (33) , is insufficient to "trigger" the PTP into the low conductance mode required for ⌬⌿ m depolarization and subsequent rapid matrix Ca 2ϩ release. Nevertheless, the mitochondrial CSA-sensitive Ca 2ϩ release pathway should still have profound effects on the activation of cytosolic Ca 2ϩ -sensitive targets, such as CaM kinase II (72) , by controlling the duration of the [Ca 2ϩ ] i spike. In summary, the properties of hepatic mitochondria devise a potentially complex feedback mechanism to modulate oscillatory Ca 2ϩ signals. The close association between ER and mitochondrial membranes (68) ensures efficient transfer of Ca 2ϩ between the organelles during IP 3 -dependent Ca 2ϩ mobilization. The initial [Ca 2ϩ ] i spike would activate Ca 2ϩ -dependent metabolic pathways in the mitochondrial matrix stimulating the respiratory chain (28, 33, 36) and increasing the driving force for mitochondrial Ca 2ϩ uptake which, in turn, suppresses the initiation of subsequent [Ca 2ϩ ] i spikes. Thus, the mitochondria may set the upper limit for the frequency of IP 3 -dependent [Ca 2ϩ ] i oscillations. A feedback mechanism, including the mitochondria balances the need for stimulating ATP production without exposing the mitochondria or the cytosol to excessive [Ca 2ϩ ] i signals, beyond what is required to maximally stimulate metabolism.
